Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,761.00
Bid: 1,757.50
Ask: 1,758.00
Change: 27.50 (1.59%)
Spread: 0.50 (0.028%)
Open: 1,736.00
High: 1,767.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Stocks erase losses after Spanish auction

Tue, 28th Aug 2012 11:47

- Spanish bond auction lifts sentiment- Miners lower on concerns over Japan- Chemring drops profit warning.London's blue-chip index was trading broadly flat by midday, having erased all of the morning's losses, after a solid Spanish bond auction eased concerns about the heavily indebted Eurozone country.Miners were providing a drag on the FTSE 100 this morning on concerns about Japan, the world's third-largest economy. The Japanese government has reduced its view on personal consumption, housing construction, exports, imports and industrial output for the first 10 months of the year. "The Japanese economy is on the way to recovery at a moderate pace, partly due to reconstruction demand, while some weak movements are seen recently," the Cabinet Office said in its monthly report. JPMorgan Securities Japan and BNP Paribas are forecasting a 0.3% and 0.9% decline in third-quarter Japanese gross domestic product (GDP), respectively.Turning to Spain, the Treasury raised €3.607bn in short-term debt this morning, above the top-end of its target rage of €2.5-3.5bn. Borrowing costs dropped dramatically and demand increased significantly compared with the previous auction in July. According to the country's national statistics institute, Spanish GDP declined at a 1.3% annual rate in the second quarter, compared with the initial estimate of a 1% contraction. Markets continue to wait official news from the European Central Bank (ECB) regarding its proposed bond-buying programme. However, analyst Craig Erlam from Alpari said that recent market chatter has shown some consistency: "There have been numerous reports recently that claim to have inside knowledge on the matter. While they all differ slightly, there is also a lot of consistency. Based on these reports, it looks likely that the ECB will target short term debt yields, which will include a non-fixed yield cap on Spanish and Italian bonds," he said.However, ECB member Jörg Asmussen has said over the weekend that the EFSF bailout fund must take the lead in the purchase of any sovereign debt before the ECB steps in. "The ECB council will continue to decide in full independence whether, when and how it will purchase bonds on the secondary market," he said.FTSE 100: Kingfisher, G4S and miners weigh on benchmark indexB&Q owner Kingfisher was the heaviest faller of the day after Bank of America Merrill Lunch downgraded its rating on the stock to 'underperform'. Security giant G4S fell after expressing disappointment over the problems related to its Olympics contract, saying that it will incur a £50m loss on the contract in the first half. Meanwhile, the company said that a restructuring of its overhead structure will lead the loss of 1,100 jobs. Nevertheless, the firm revealed that turnover at constant exchange rates rose 7.5% while profits were flat. Miners were firmly out of favour this morning on concerns over the Japanese economy. BHP Billiton fell after announcing the sale of its Yeelirrie uranium deposit in Western Australia to Cameco for $430m. BHP and sector peers ENRC, Kazakhmys and Vedanta were also lower after Morgan Stanley reduced its target price for all four stocks. Drugs giant AstraZeneca was lower after saying that it has appointed Roche's Chief Operating Officer as its new Chief Executive Officer. Meanwhile, the firm also announced that the European Commission has granted marketing authorisation to its ZINFORO treatment. Sector peer GlaxoSmithKline was suffering from a downgrade by UBS.Bunzl, the international distribution and outsourcing group, fell despite saying that pre-tax profits and revenues in the first half rose 9% and 7%, respectively. FTSE 250: Chemring drops after profit warningDefence contractor Chemring dropped after it issued a profits warning, saying a computer glitch and production delays are likely to wipe £15m off full-year earnings as it considers a takeover offer from private equity giant Carlyle.Heading the other way was chemicals group Yule Catto after reporting a pre-tax profit of £56m in the first half, up from £52.4m the year before. Sales, however, fell to £603.3m from £664.3m.FTSE 100 - RisersITV (ITV) 85.00p +1.74%Carnival (CCL) 2,128.00p +1.72%Barclays (BARC) 190.20p +1.60%CRH (CRH) 1,149.00p +1.59%Fresnillo (FRES) 1,606.00p +1.52%Capital Shopping Centres Group (CSCG) 332.90p +1.22%United Utilities Group (UU.) 719.50p +1.20%BT Group (BT.A) 217.50p +1.07%Sainsbury (J) (SBRY) 332.60p +0.94%Glencore International (GLEN) 370.00p +0.86%FTSE 100 - FallersKingfisher (KGF) 275.60p -3.54%Evraz (EVR) 239.70p -2.88%Kazakhmys (KAZ) 642.00p -2.80%G4S (GFS) 259.10p -2.67%Eurasian Natural Resources Corp. (ENRC) 330.50p -2.48%Bunzl (BNZL) 1,084.00p -2.43%Vedanta Resources (VED) 906.00p -2.00%Marks & Spencer Group (MKS) 364.30p -1.99%IMI (IMI) 840.50p -1.93%InterContinental Hotels Group (IHG) 1,587.00p -1.79%FTSE 250 - RisersYule Catto & Co (YULC) 152.80p +7.76%Moneysupermarket.com Group (MONY) 138.10p +5.42%Ted Baker (TED) 1,000.00p +3.41%Renishaw (RSW) 1,568.00p +2.55%Dialight (DIA) 1,099.00p +2.33%Imagination Technologies Group (IMG) 578.50p +2.12%Home Retail Group (HOME) 95.15p +2.04%Homeserve (HSV) 216.30p +1.93%St. Modwen Properties (SMP) 202.40p +1.71%COLT Group SA (COLT) 119.20p +1.71%FTSE 250 - FallersChemring Group (CHG) 324.00p -12.55%Bumi (BUMI) 335.30p -5.55%Heritage Oil (HOIL) 191.00p -4.45%Cairn Energy (CNE) 285.10p -3.78%BTG (BTG) 310.30p -2.64%Afren (AFR) 126.80p -2.39%Cape (CIU) 188.50p -2.38%Bwin.party Digital Entertainment (BPTY) 92.90p -2.26%Perform Group (PER) 372.00p -2.11%NMC Health (NMC) 193.00p -2.03%BC
More News
Today 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.